1. Management of myelodysplastic syndromes in the geriatric patient

   • Ellen K. Ritchie
   • Mark S. Lachs

   OriginalPaper 24 December 2008 Pages: 3 - 9

2. Myelodysplastic syndrome: An update on diagnosis and therapy

   • Ahrin Koppel
   • Gary Schiller

   OriginalPaper 24 December 2008 Pages: 10 - 16

3. New and old prognostic factors in polycythemia vera

   • Francesco Passamonti

   OriginalPaper 24 December 2008 Pages: 19 - 24

4. Do we know more about essential thrombocythemia because of JAK2V617F?

   • Claire Harrison

   OriginalPaper 24 December 2008 Pages: 25 - 32

5. The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis

   • Juergen Thiele
   • Hans Michael Kvasnicka

   OriginalPaper 24 December 2008 Pages: 33 - 40

6. Use of alemtuzumab and rituximab consolidation in CLL: Pros and cons

   • Thomas Elter
   • Barbara F. Eichhorst
   • Clemens-Martin Wendtner

   OriginalPaper 24 December 2008 Pages: 43 - 46

7. Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia

   • Anders Österborg
   • Claes Karlsson
   • Jeanette Lundin

   OriginalPaper 24 December 2008 Pages: 47 - 53